Getinge (OTCMKTS:GNGBY – Get Free Report) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its rivals? We will compare Getinge to related businesses based on the strength of its dividends, earnings, profitability, valuation, analyst recommendations, risk and institutional ownership.
Dividends
Getinge pays an annual dividend of $0.29 per share and has a dividend yield of 1.0%. Getinge pays out 26.4% of its earnings in the form of a dividend. As a group, “Healthcare Providers & Services” companies pay a dividend yield of 1.4% and pay out 25.8% of their earnings in the form of a dividend. Getinge lags its rivals as a dividend stock, given its lower dividend yield and higher payout ratio.
Valuation & Earnings
This table compares Getinge and its rivals top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Getinge | $3.57 billion | $230.87 million | 25.37 |
| Getinge Competitors | $19.23 billion | $301.67 million | -1.65 |
Profitability
This table compares Getinge and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Getinge | 8.20% | 11.55% | 6.15% |
| Getinge Competitors | -7.87% | -135.89% | -1.58% |
Insider and Institutional Ownership
56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 15.0% of shares of all “Healthcare Providers & Services” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Risk and Volatility
Getinge has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Comparatively, Getinge’s rivals have a beta of 0.98, indicating that their average share price is 2% less volatile than the S&P 500.
Analyst Ratings
This is a summary of recent recommendations and price targets for Getinge and its rivals, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Getinge | 0 | 4 | 0 | 0 | 2.00 |
| Getinge Competitors | 1880 | 7755 | 13395 | 833 | 2.55 |
As a group, “Healthcare Providers & Services” companies have a potential upside of 12.77%. Given Getinge’s rivals stronger consensus rating and higher possible upside, analysts plainly believe Getinge has less favorable growth aspects than its rivals.
Summary
Getinge rivals beat Getinge on 11 of the 15 factors compared.
About Getinge
Getinge is a Swedish medical technology company that develops products and services for hospitals and life science organizations. Its offerings support patient care, surgical procedures, infection prevention and the production of medicines and other biological products. The company’s portfolio includes equipment and solutions for intensive care, cardiovascular procedures and operating rooms, as well as sterilization and cleaning systems. Its life science business provides solutions used in areas such as pharmaceutical and biotechnology manufacturing.
Receive News & Ratings for Getinge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge and related companies with MarketBeat.com's FREE daily email newsletter.
